<DOC>
	<DOCNO>NCT02114359</DOCNO>
	<brief_summary>The investigator compare overall survival combination chemotherapy monochemotherapy first-line chemotherapy elderly patient metastatic recurrent gastric cancer . The investigator also compare progression free survival , response rate , safety , , quality life two group , evaluate comprehensive geriatric assessment test baseline predict toxicity compliance treatment , survival patient .</brief_summary>
	<brief_title>Chemotherapy Options First Line Chemotherapy Elderly Patient With Advanced Gastric Cancer</brief_title>
	<detailed_description />
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>.Metastatic recurrent , histologically confirm adenocarcinoma stomach Previously untreated patient , include patient previous adjuvant chemotherapy complete 6 month 70 yrs old Eastern Cooperative Oncology Group 02 Measurable evaluable disease Adequate major organ function Hb ≥ 9.0 g/dL White blood cell count ≥ 3000/μL Absolute Neutrophil Count ( ANC ) ≥ 1500/μL [ *ANC = neutrophil segs ＋ neutrophil band ] Platelet ≥ 100 × 103/ μL Total bilirubin ≤ 1.5 ×UNL , aspartate aminotransferase ( AST ) /alanine aminotransferase ( ALT ) ≤ 3.0x UNL ( case liver metastasis , AST/ALT ≤ 5.0 x UNL ) Serum creatinine ≤ 1.5 × UNL ( case serum creatinine &gt; 1.5 mg/dL , Ccr &gt; = 50 mL/min , Ccr calculate CockcroftGault 24hr urine collection ) Life expectancy &gt; 3month Written inform consent Metastatic recurrent stomach cancer adenocarcinoma HER2 positive Clinically significant , uncontrolled gastric outlet obstruction , bleeding , perforation Radiation therapy within previous 2wks Major surgery trauma within previous 4wks Other malignancy within last 5 year ( curatively treat basal cell carcinoma skin and/or situ carcinoma cervix ) Uncontrolled brain metastasis Presence serious disease ( cardiovascular , hepatic , infection etc . ) Patients participate clinical trial within previous 30days Men childbearing potential willing use effective mean contraception</criteria>
	<gender>All</gender>
	<minimum_age>70 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>gastric cancer , elderly , chemotherapy</keyword>
</DOC>